Does renal artery supply indicate treatment success of renal denervation?

CardioVascular and Interventional Radiology

Volumn 36, Issue 4, 2013, Pages 987-991

  Schmid, Axel ^a   Ditting, Tilmann ^a   Sobotka, Paul A ^b,c   Veelken, Roland ^a   Schmieder, Roland E ^a   Uder, Michael ^a   Ott, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

^c Coridea NC1 ^*  (United States)

Author keywords

Ablation; Artery; Endovascular treatment; Hypertension; Kidney renal; Radiofrequency ablation

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ALDOSTERONE ANTAGONIST; ALISKIREN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; VASODILATOR AGENT;

ABLATION THERAPY; ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD VESSEL; CATHETER; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG CONTRAINDICATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DENERVATION; MAJOR CLINICAL STUDY; MALE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RENAL ARTERY; RENAL ARTERY SUPPLY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANGIOGRAPHY; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CATHETER ABLATION; COHORT STUDIES; DENERVATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; RENAL ARTERY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84879942103     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0652-9     Document Type: Article

References (15)

1. Atherton DS, Deep NL, Mendelsohn FO (2012) Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 25:628-633
2. Calhoun DA, Jones D, Textor S et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117:e510-e526
3. Esler MD, Krum H, Sobotka PA et al (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903-1909
4. Kandzari DE, Bhatt DL, Sobotka PA et al (2012) Catheter-based renal denervation for resistant hypertension: rationale and design of the Symplicity HTN-3 Trial. Clin Cardiol 35:528-535
5. Kearney PM, Whelton M, Reynolds K et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217-223
6. Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275-1281
7. Lorenz EC, Vrtiska TJ, Lieske JC et al (2010) Prevalence of renal artery and kidney abnormalities by computed tomography among healthy adults. Clin J Am Soc Nephrol 5:431-438
8. Mancia G, De Backer G, Dominiczak A et al (2007) 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25:1105-1187
9. Mancia G, Laurent S, Agabiti-Rosei E et al (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27:2121-2158
10. Persu A, Renkin J, Thijs L, Staessen JA (2012) Renal denervation: ultima ratio or standard in treatment-resistant hypertension. Hypertension 60:596-606
11. Rippy MK, Zarins D, Barman NC et al (2011) Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety. Clin Res Cardiol 100:1095-1101
12. Satyapal KS, Haffejee AA, Singh B et al (2001) Additional renal arteries: incidence and morphometry. Surg Radiol Anat 23:33-38
13. Schlaich MP, Sobotka PA, Krum H et al (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 361:932-934
14. Schmieder RE, Redon J, Grassi G et al (2012) ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens 30:837-841
15. Symplicity HTN-1 Investigators (2011) Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57:911-917